Nutra Pharma Corp. (NPHC)

OTCMKTS · Delayed Price · Currency is USD
0.0003
0.00 (0.00%)
Apr 28, 2026, 4:00 PM EST
200.00%
Market Cap 2.15M
Revenue (ttm) 452.77K
Net Income (ttm) -1.79M
Shares Out 7.16B
EPS (ttm) -0.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 234,100
Average Volume 302,386
Open 0.0003
Previous Close 0.0003
Day's Range 0.0001 - 0.0003
52-Week Range 0.0000 - 0.0050
Beta 66.62
RSI 70.87
Earnings Date Apr 29, 2026

About Nutra Pharma

Nutra Pharma Corp., a biopharmaceutical company, acquires, licenses, and commercializes pharmaceutical products and technologies, and drugs for the management of pain, neurological disorders, cancer, and autoimmune and infectious diseases in the United States. The company offers Nyloxin, an over-the-counter (OTC) pain reliever; Nyloxin Extra Strength, a non-narcotic and non-addictive treatment for severe pain; Pet Pain-Away, an OTC pain reliver for dogs and cats; Equine Pain-Away, an OTC topical pain reliever to relieve pain in horses; and Luxu... [Read more]

Sector Healthcare
Founded 2000
Employees 6
Stock Exchange OTCMKTS
Ticker Symbol NPHC
Full Company Profile

Financial Performance

In 2024, Nutra Pharma's revenue was $392,150, a decrease of -34.08% compared to the previous year's $594,880. Losses were -$1.29 million, -7.73% less than in 2023.

Financial Statements

News

There is no news available yet.